Belgium
-
ASIT Biotech, a Belgian company developing remedies for allergies including hay fever, priced its IPO on Wednesday, raising €23.5m, and made its debut on Euronext Paris and Brussels on Thursday. -
Groupe Bruxelles Lambert, the Belgian investment holding company, won a bigger than expected take-up for its buyback of bonds exchangeable into shares of Engie this week.
-
-
Investors poured into Belgium’s debut 50 year benchmark vintage this week, with demand so strong that bankers are confident other issuers could soon sip liquidity from the ultra-long tenor.
-
-
Belgium cracked open its 50 year bond vintage on Thursday with a deal that drew plenty of praise — while the level of demand even surprised some of those working on the trade.
-
The low interest rate environment is causing investors to look at longer and longer paper in search of yield. Issuers are seizing the chance for long funding with private placements.
-
Thursday was the busiest day of the year so far for euro bank capital, as FIG borrowers betrayed nerves over how long investors’ risk appetite might last.
-
Belgium is set to bring a private dabbling in ultra-long debt issuance into the public sphere, as it mandated on Wednesday for a debut 50 year euro benchmark a week after placing its second 100 year medium term note.
-
-
KBC showed holdco pricing has not yet reached consensus, as bankers struggled to agree on fair value for the bank’s blowout senior debut this week.
-
KBC was more than 10 times oversubscribed for its holding company-issued senior debut on Wednesday, providing further evidence of the asset class's growing success in Europe.
